Wijziging van de Geneesmiddelenwet ter implementatie van richtlijn 2011/62/EU om te verhinderen dat vervalste geneesmiddelen in de legale distributieketen belanden

This procedure concerns the amendment of the Medicines Act to implement EU Directive 2011/62/EU. The goal is to strengthen the security of the pharmaceutical supply chain to prevent counterfeit or falsified medicines from reaching patients. This affects pharmaceutical manufacturers, distributors, and pharmacists. It introduces stricter controls and verification requirements to ensure the authenticity of medicines sold within the legal market.